Alzheimer's disease (AD) is a chronic neurodegenerative disorder that is mainly characterized by betaamyloid (Ab) plaque deposition, Tau pathology and dysfunction of the cholinergic system causing memory impairment. The aim of the present study was to examine (1) anxiety and cognition, (2) Ab plaque deposition and (3) degeneration of cholinergic neurons in the nucleus basalis of Meynert (nbM) and cortical cholinergic innervation in an Alzheimer mouse model (APP_SweDI; overexpressing amyloid precursor protein (APP) with the Swedish K670N/M671L, Dutch E693Q, and Iowa D694N mutations). Our results show that 12-month-old APP_SweDI mice were more anxious and had more memory impairment. A large number of Ab plaques were already visible at the age of 6 months and increased with age. A significant decrease in cholinergic neurons was seen in the transgenic mouse model in comparison to the wild-type mice, identified by immunohistochemistry against choline acetyltransferase (ChAT) and p75 neurotrophin receptor as well as by in situ hybridization. Moreover, a significant decrease in cortical cholinergic fiber density was found in the transgenic mice as compared to the wild-type. In the cerebral cortex of APP_SweDI mice, swollen cholinergic varicosities were seen in the vicinity of Ab plaques. In conclusion, the present study shows that in an AD mouse model (APP_SweDI mice) a high Ab plaque load in the cortex causes damage to cholinergic axons in the cortex, followed by subsequent retrograde-induced cell death of cholinergic neurons and some forms of compensatory processes. This degeneration was accompanied by enhanced anxiety and impaired cognition.
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Introduction
Alzheimer's disease (AD) is a chronic neurodegenerative disorder that accounts for most cases of dementia in the elderly population. The neuropathological hallmarks of AD are beta-amyloid (Ab) plaque deposits, Tau neurofibrillary tangles, neuronal and synaptic loss, inflammation and cerebrovascular damage. Senile Ab plaques consist mainly of insoluble deposits of 40-or 42-amino acid long Ab peptides that are produced by sequential cleavage of the transmembrane glycoprotein amyloid precursor protein (APP) (Selkoe, 2001) . It has been shown that mutations in human APP are associated with early onset familial AD (Chartier-Harlin, Crawford, Houlden, et al., 1991; Goate et al., 1991; Murrell, Farlow, Ghetti, & Benson, 1991) . The exact processes of genesis of Ab plaques in AD is not entirely understood, but the Ab cascade is the most prominent hypothesis for the development of AD (Hardy & Higgins, 1992; Marchesi, 2005; Reitz, 2012) , suggesting that the excessive accumulation of insoluble Ab peptides induces a series of events that leads to neuronal dysfunction and death.
Degeneration of the basal forebrain cholinergic system is an important pathophysiology of AD (Perry et al., 1978; Schliebs & Arendt, 2006) . Cholinergic neurons provide the main source of acetylcholine (ACh) in the cortex and a decline in ACh directly correlates with cognitive impairment (Perry et al., 1978) . The number of cholinergic neurons has consistently been found to be reduced in the basal forebrain of advanced AD (Davies & Maloney, 1976; Whitehouse, Price, Struble, & Clarke, 1982) , accompanied by decreases in choline acetyltransferase (ChAT) activity (Lehéricy et al., 1993; Wilcock, Esiri, Bowen, & Smith, 1982) . A lack of ACh in the cerebral cortex directly correlates with cognitive decline. These findings led to the cholinergic hypothesis of AD (Francis, Palmer, Snape, & Wilcock, 1999) , proposing that the loss of basal
